Tue Sep 17 07:00:06 UTC 2024: ## AI-Powered Healthcare Solutions Team Up to Improve Patient Access and Reduce Costs

**VANCOUVER, British Columbia, Sept. 17, 2024 (GLOBE NEWSWIRE)** – Treatment.com AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) has announced a collaborative agreement with SPRYT Limited, both companies dedicated to developing innovative AI healthcare solutions.

The partnership aims to leverage the strengths of both companies to create new solutions that address patient access challenges, streamline administrative processes for healthcare professionals, and reduce costs for the entire healthcare system.

Treatment.com’s Global Library of Medicine (GLM) uses AI to analyze patient symptoms and medical history, suggesting likely diagnoses and necessary tests, while SPRYT’s AI Medical Office Assistant (MOA), “Asa,” helps patients schedule appointments, make payments, and reduces no-show rates through personalized messaging and behavioral science.

The combined technology offers the potential for a seamless and efficient healthcare experience. Patients can access information and manage appointments through instant messaging, while healthcare professionals can utilize AI to expedite diagnosis, optimize triaging, and reduce administrative burdens.

“We are excited about this collaboration with SPRYT, which has a strong presence in the UK and is expanding globally,” said Dr. Essam Hamza, CEO of Treatment.com AI. “Our combined AI technologies aim to not only reduce missed appointments but also streamline the entire patient journey, leading to better outcomes and cost savings.”

Daragh Donohue, Founder and CEO of SPRYT, added, “This partnership allows us to leverage our complementary technologies to create a more accessible, efficient, and patient-centric healthcare ecosystem. By combining Asa’s appointment management capabilities with Treatment.com’s medical history analysis, we can significantly improve the patient experience while alleviating the administrative burden on healthcare providers.”

This collaboration, with its potential to revolutionize the healthcare landscape, will be explored in the UK, North America, and the Middle East, where both companies have existing operations.

Read More